March 26, 2025 05:09 PM EDTUpdated March 27, 07:27 AM

FDA approves first drug for Prader-Willi syndrome, to tamp down insatiable hunger symptoms

Max Gelman

Senior Editor

The FDA on Wednesday approved Soleno Therapeutics’ new drug designed to treat the worst symptom of a debilitating rare disease known as Prader-Willi syndrome. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

FDA approves first drug for Prader-Willi syndrome, to tamp down insatiable hunger symptoms

Max Gelman

Senior Editor

Sign up to read this article for free.

Uro-Oncology Business Manager

ImmunityBio, Inc.

Remote

FDA's Peter Marks resigns, saying he won't accept Kennedy's 'misinformation and lies'

Bluebird gets new M&A bid, seeking to top private equity offer

‘People will die’: End of NIH grants guts work between academics and companies to counter next pandemic

Small biotech joins list of health companies taking a trip to Trump's Mar-a-Lago

BioNTech details promising mid-stage data for its PD-L1xVEGF in aggressive lung cancer

Novo inks second obesity deal of the week, with Lexicon oral drug partnership worth up to $1B

FDA ap­proves first drug for Prad­er-Willi syn­drome, to tamp down in­sa­tiable hunger symp­toms

Senior Editor

Sign up to read this article for free.

more like this

ImmunityBio, Inc.

Remote

FDA approves first drug for Prader-Willi syndrome, to tamp down insatiable hunger symptoms